Lindsay J Blazin1, Andrea Cuviello2, Holly Spraker-Perlman2, Erica C Kaye2. 1. Department of Pediatrics, Division of Pediatric Hematology and Oncology, Indiana University, 705 Riley Hospital Dr., Suite 4340, Indianapolis, IN, 46202, USA. lblazin@iu.edu. 2. Department of Oncology, Division of Quality of Life & Palliative Care, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 260, Memphis, TN, 38105, USA.
Abstract
PURPOSE OF REVIEW: This manuscript aims to describe evidence-based best practices to guide clinicians in communicating with pediatric patients and their families about clinical trial enrollment. RECENT FINDINGS: The standard paradigm for discussing clinical trial enrollment with pediatric oncology patients and their families inconsistently enables or facilitates true informed consent. Evidence exists to suggest that adopting a shared decision-making approach may improve patient and family understanding. When navigating communication about clinical trials, clinicians should integrate the following evidence-based communication approaches: (1) extend dialogue about clinical trial enrollment across multiple conversations, allowing families space and time to process information independently; (2) use core communication skills such as avoiding jargon, checking for understanding, and responding to emotion. Clinicians should consider factors at the individual, team, organizational, community, and policy levels that may impact clinical trial communication with pediatric cancer patients and their families. This article reviews learnable skills that clinicians can master to optimize communication about clinical trial enrollment with pediatric cancer patients and their families.
PURPOSE OF REVIEW: This manuscript aims to describe evidence-based best practices to guide clinicians in communicating with pediatric patients and their families about clinical trial enrollment. RECENT FINDINGS: The standard paradigm for discussing clinical trial enrollment with pediatric oncology patients and their families inconsistently enables or facilitates true informed consent. Evidence exists to suggest that adopting a shared decision-making approach may improve patient and family understanding. When navigating communication about clinical trials, clinicians should integrate the following evidence-based communication approaches: (1) extend dialogue about clinical trial enrollment across multiple conversations, allowing families space and time to process information independently; (2) use core communication skills such as avoiding jargon, checking for understanding, and responding to emotion. Clinicians should consider factors at the individual, team, organizational, community, and policy levels that may impact clinical trial communication with pediatric cancer patients and their families. This article reviews learnable skills that clinicians can master to optimize communication about clinical trial enrollment with pediatric cancer patients and their families.
Authors: Liza-Marie Johnson; Angela C Leek; Dennis Drotar; Robert B Noll; Susan R Rheingold; Eric D Kodish; Justin N Baker Journal: Cancer Date: 2015-04-14 Impact factor: 6.860
Authors: Melissa K Cousino; Stephen J Zyzanski; Amy D Yamokoski; Rebecca A Hazen; Justin N Baker; Robert B Noll; Susan R Rheingold; J Russell Geyer; Stewart C Alexander; Dennis Drotar; Eric D Kodish Journal: J Clin Oncol Date: 2012-10-15 Impact factor: 44.544
Authors: Rhonda G Kost; Laura M Lee; Jennifer Yessis; Robert A Wesley; David K Henderson; Barry S Coller Journal: N Engl J Med Date: 2013-12-05 Impact factor: 91.245
Authors: Rebecca A Hazen; Stephen Zyzanski; Justin N Baker; Dennis Drotar; Eric Kodish Journal: Contemp Clin Trials Date: 2015-01-29 Impact factor: 2.226